All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study.

Ann Hematol · 2016 · PMC5093206 · PMID 27696203

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

showed a trendp = 0.09so close (0.05 < p ≤ 0.1)

However, PP analyses showed a trend for superior EFS ( p = 0.09) and a statistically significant better OS ( p = 0.03, Fig. 2 ) for patients in ATRA compared to STANDARD, but no difference in RFS ( p = 0.14).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.